Aceso Life Science Group Limited

HKEX:0474.HK

0.06 (HKD) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Operating Activities:
Net Income -462-213-555-323-267.228-480.577-525.77-3,188.848465.9741,522.378-12.459-219.326-378.458-96.609-468.024-21.3422.1828.05126.80430.185
Depreciation & Amortization 2152686356.90158.36566.87716.2828.6635.4876.6637.0758.6544.3321.9091.651.721.3992.282.388
Deferred Income Tax 0138449187163.393300.895364.9342,084.117-539.144-1,611.574-23.47150.496800.14-2.516423.26815.9280000
Stock Based Compensation 037492553.1717.7660.0072.4629.18718.26716.4230.2751.1010000
Change In Working Capital -10713221448-397.489-94.899-80.0441,517.426-571.324-1,471.439-171.495-18.11-35.26-9.8146.01613.727-5.007-14.287.606-5.835
Accounts Receivables -7811422367-300.61883.74338.253-35.096-389.03300000000000
Inventory 24912.67221.90313.5673.6460.8321.537-11.22-18.562-1.307-5.6228.6173.465-3.755-8.591.898-2.148
Accounts Payables -772-1422.356-61.76506.987000000000000
Other Working Capital -247-20-6-121.899-138.78-93.6111,513.78-572.156-1,472.976-160.2750.452-33.953-4.18837.39910.262-1.252-5.695.708-3.687
Other Non Cash Items 47311013315584.453127.29378.793109.5684.0664.7914.5431.909-506.35625.68127.2465.00112.7973.123-15.997-11.919
Operating Cash Flow -200222316179-356.316-83.923-90.21541.708-544.005-1,490.35-193.756-68.769-93.013-62.49930.6916.06731.6918.29320.69314.819
Investing Activities:
Investments In Property Plant And Equipment -11-47-57-15-36.183-70.734-72.576-29.333-5.631-15.468-5.233-91.915-114.481-198.536-2.178-0.77-3.167-0.665-5.876-1.277
Acquisitions Net 5174418.24995.764-102.321-794.27960.38512.397757.6981,374.3690-250-192.4571.9981.36200-2.02
Purchases Of Investments 0-112-76-3-320-13.243-275.2029.687-25-42.935-688.439-254.350-3.988-0.613-20.474-25.802-1.560-3.337
Sales Maturities Of Investments 450104141,432.007112.98494.75275.80643.557371.053206.88330.0720.56111.97719.9933.0170.704000.069
Other Investing Activites 3312-35315-99.776-1,372.17833.727118.965-114.5412.848-42.748-278.215-4.5930.5276.645-5.3175.6523.6793.183.987
Investing Cash Flow 472-120-441-10994.297-1,247.407-321.62-619.154-41.23327.895228.161779.961-118.513-440.02-168.61-21.546-21.2511.454-2.696-2.578
Financing Activities:
Debt Repayment -145-599-574-682-561.425-1,036.121-1,278.156-1,485.714-1,104.801-179-612.407-639.3490-9.080-4.8530-0.78-0.869-0.425
Common Stock Issued 00021700159.927244.405266.589496.1656.7448.0860327.681701.1061.3191.266000
Common Stock Repurchased 0-9-5000-3.0770000000000000
Dividends Paid 00000000000000-5.028-10.287-10.141-10-20-10
Other Financing Activities 4205107059039.6341,860.2691,476.3581,846.7861,518.763633.716699.301160.33206.565-70.254-310.921-0.1574.806-0.229-0.216-0.32
Financing Cash Flow -161-98126-375-521.791824.148355.052605.477680.551950.88193.638-470.933206.565248.347385.157-13.978-4.069-11.009-21.085-10.745
Other Information:
Effect Of Forex Changes On Cash 8-12-412-1.506-7.20921.837-7.441-3.109-1.1731.0170.0323.2560.1770.775-1.4484.7181.063-0.4270.003
Net Change In Cash 152-8-3-184114.684-514.391-34.941520.5992.207-212.747129.06240.291-1.705-253.995248.012-20.90511.0889.801-3.5151.499
Cash At End Of Period 369187195198381.724267.04781.431816.372295.782203.575416.322287.26246.97148.676302.67154.65975.56464.47654.67558.19